Tag: Cancer: Breast
FDA Approves First Immunotherapy Drug for Breast Cancer
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
Genetic Testing Recommended for All Patients With Breast Cancer
All with personal history of breast cancer should be offered testing; updated testing recommended
Recall Down, Cancer Detection Up With Digital Breast Tomosynthesis
Breast cancers detected by DBT less often classified as having poor prognosis than those identified by DM
Breast Cancer Diagnosis Delays Seen With High-Deductible Health Plans
Delays observed in first breast imaging, biopsy, incident early-stage breast cancer diagnosis, chemo
Performance Improvement Sustained After DBT Adoption
Early improvement after adoption of digital breast tomosynthesis seen regardless of DBT volume
Robotically Assisted Devices Not Approved for Cancer Surgery
FDA aware that surgeons have been using the devices for uses not granted marketing authorization
FDA: Thermography No Substitute for Mammograms
Agency is taking action to stop false advertising about thermography
One-Third of PCPs Discuss Breast Cancer Treatments With Patients
However, many report feeling uncomfortable or believing they lack the necessary knowledge
Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer
Response rate of 33.3 percent, median response duration of 7.7 months observed in 108 patients
Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
Incremental cost-effectiveness ratio varies across clinical risk groups, sensitive to patient age
